Skip to main content
logo
Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
6.85
-0.31 (-4.33%)
May 8, 2026, 4:00 PM EDT - Market closed

Profound Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
250286238173221217
Market Cap Growth
76.34%20.47%36.97%-21.60%2.06%-44.03%
Enterprise Value
206.38230.66183.14153.34182.42155.67
PE Ratio
-5.576.726.257.737.52
PS Ratio
13.2917.7021.1824.8533.3534.10
PB Ratio
4.214.293.745.734.282.91
P/TBV Ratio
3.674.904.437.525.803.62
P/FCF Ratio
--7.42-9.64-7.91-8.64-10.47
P/OCF Ratio
--7.46-9.64-7.91-8.64-10.48
EV/Sales Ratio
10.9714.2716.3321.9727.5024.49
EV/EBITDA Ratio
--5.64-5.43-5.71-6.02-5.92
EV/EBIT Ratio
--5.57-5.28-5.52-5.72-5.56
EV/FCF Ratio
--5.98-7.44-7.00-7.12-7.52
Debt / Equity Ratio
0.050.070.050.180.140.01
Debt / EBITDA Ratio
-0.20-0.12-0.16-0.28-0.27-0.05
Debt / FCF Ratio
-0.19-0.12-0.22-0.35-0.32-0.06
Net Debt / Equity Ratio
-0.72-0.83-0.82-0.59-0.74-0.82
Net Debt / EBITDA Ratio
1.141.351.550.661.252.32
Net Debt / FCF Ratio
1.111.432.120.811.482.94
Asset Turnover
0.250.220.190.130.090.07
Inventory Turnover
0.630.670.570.390.480.62
Quick Ratio
5.6411.079.445.2612.6317.37
Current Ratio
6.5612.5210.526.5814.8218.56
Return on Equity (ROE)
-61.82%-67.12%-60.70%-68.06%-43.23%-34.50%
Return on Assets (ROA)
-50.81%-56.19%-57.90%-52.63%-42.50%-31.76%
Return on Invested Capital (ROIC)
-255.58%-352.53%-257.99%-188.08%-198.84%-180.12%
Return on Capital Employed (ROCE)
-56.77%-61.09%-65.30%-58.58%-44.98%-33.21%
Earnings Yield
-15.56%17.96%14.87%16.01%12.93%13.30%
FCF Yield
-15.47%-13.47%-10.37%-12.64%-11.58%-9.55%
Buyback Yield / Dilution
-21.35%-22.08%-16.91%-1.69%-1.79%-18.33%
Total Shareholder Return
-21.35%-22.08%-16.91%-1.69%-1.79%-18.33%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q